{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T17:26:54Z","timestamp":1785691614904,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mutations in NF1 gene could cause allelic disorders with clinical spectrum of Neurofibromatosis type 1 to Noonan syndrome. Here, a 7-year-old Iranian girl is described with Neurofibromatosis-Noonan syndrome due to a pathogenic variant in NF1 gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Clinical evaluations were performed along with genetic testing using whole exome sequencing (WES). The variant analysis including pathogenicity prediction was also done using bioinformatics tools.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The chief compliant of the patient was short stature and lack of proper weight gain. Other symptoms were developmental delay, learning disability, inadequate speech skill, broad forehead, hypertelorism, and epicanthal folds, low set ears and webbed neck. A small deletion, c.4375-4377delGAA, was found in NF1 gene using WES. This variant was classified as pathogenic according to ACMG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>NF1 variants may show variable phenotypes among the patients; identifying such variants is helpful in therapeutic management of the disease. WES is considered as an appropriate test to diagnose Neurofibromatosis-Noonan syndrome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40246-023-00460-0","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T06:08:03Z","timestamp":1676873283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene"],"prefix":"10.1186","volume":"17","author":[{"given":"Setila","family":"Dalili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyedeh Azade","family":"Hoseini Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Koohmanaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manijeh","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjaneh","family":"Zarkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Tarang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejat","family":"Mahdieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"460_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12887-021-02791-0","volume":"21","author":"E Pinti","year":"2021","unstructured":"Pinti E, Nemeth K, Staub K, Lengyel A, Fekete G, Haltrich I. Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. BMC Pediatr. 2021;21:331.","journal-title":"BMC Pediatr"},{"key":"460_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/archdischild-2021-322858","volume":"107","author":"M Zenker","year":"2022","unstructured":"Zenker M, Edouard T, Blair JC, Cappa M. Noonan syndrome: improving recognition and diagnosis. Arch Dis Childhood. 2022;107:1073\u20138.","journal-title":"Arch Dis Childhood."},{"key":"460_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104371","volume":"65","author":"S Garcia-Minaur","year":"2022","unstructured":"Garcia-Minaur S, Burkitt-Wright E, Verloes A, Shaikh G, Lebl J, Ostman-Smith I, et al. European Medical Education Initiative on Noonan syndrome: a clinical practice survey assessing the diagnosis and clinical management of individuals with Noonan syndrome across Europe. Eur J Med Genet. 2022;65: 104371.","journal-title":"Eur J Med Genet"},{"issue":"61","key":"460_CR4","first-page":"e1","volume":"93","author":"A Carcavilla","year":"2020","unstructured":"Carcavilla A, Suarez-Ortega L, Rodriguez Sanchez A, Gonzalez-Casado I, Ramon-Krauel M, Labarta JI, et al. Noonan syndrome: genetic and clinical update and treatment options. Anales de pediatria. 2020;93(61):e1-61.","journal-title":"Anales de pediatria."},{"key":"460_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","volume":"381","author":"AE Roberts","year":"2013","unstructured":"Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet. 2013;381:333\u201342.","journal-title":"Lancet"},{"key":"460_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/humu.20955","volume":"30","author":"A Sarkozy","year":"2009","unstructured":"Sarkozy A, Carta C, Moretti S, Zampino G, Digilio MC, Pantaleoni F, et al. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat. 2009;30:695\u2013702.","journal-title":"Hum Mutat"},{"key":"460_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng1748","volume":"38","author":"S Schubbert","year":"2006","unstructured":"Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006;38:331\u20136.","journal-title":"Nat Genet"},{"key":"460_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/jmg.2007.050450","volume":"44","author":"C Nava","year":"2007","unstructured":"Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Niihori T, et al. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS\/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet. 2007;44:763\u201371.","journal-title":"J Med Genet"},{"key":"460_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91225","volume":"2","author":"EM Higgins","year":"2017","unstructured":"Higgins EM, Bos JM, Mason-Suares H, Tester DJ, Ackerman JP, MacRae CA, et al. Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy. JCI Insight. 2017;2: e91225.","journal-title":"JCI Insight"},{"key":"460_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ejhg.2017.65","volume":"25","author":"F Altmuller","year":"2017","unstructured":"Altmuller F, Lissewski C, Bertola D, Flex E, Stark Z, Spranger S, et al. Genotype and phenotype spectrum of NRAS germline variants. Eur J Hum Genet EJHG. 2017;25:823\u201331.","journal-title":"Eur J Hum Genet EJHG"},{"key":"460_CR11","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/340847","volume":"70","author":"M Tartaglia","year":"2002","unstructured":"Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002;70:1555\u201363.","journal-title":"Am J Hum Genet"},{"key":"460_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2015.114","volume":"61","author":"Y Aoki","year":"2016","unstructured":"Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASopathies. J Hum Genet. 2016;61:33\u20139.","journal-title":"J Hum Genet"},{"key":"460_CR13","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1073\/pnas.1324128111","volume":"111","author":"PC Chen","year":"2014","unstructured":"Chen PC, Yin J, Yu HW, Yuan T, Fernandez M, Yung CK, et al. Next-generation sequencing identifies rare variants associated with Noonan syndrome. Proc Natl Acad Sci USA. 2014;111:11473\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"460_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ejhg.2012.221","volume":"21","author":"S Ben-Shachar","year":"2013","unstructured":"Ben-Shachar S, Constantini S, Hallevi H, Sach EK, Upadhyaya M, Evans GD, Huson SM. Increased rate of missense\/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation. Eur J Hum Genet EJHG. 2013;21:535\u20139.","journal-title":"Eur J Hum Genet EJHG"},{"key":"460_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1399-0004.2009.01233.x","volume":"76","author":"AM Nystrom","year":"2009","unstructured":"Nystrom AM, Ekvall S, Allanson J, Edeby C, Elinder M, Holmstrom G, et al. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1. Clin Genet. 2009;76:524\u201334.","journal-title":"Clin Genet"},{"key":"460_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ajmg.1320210307","volume":"21","author":"JE Allanson","year":"1985","unstructured":"Allanson JE, Hall JG, Van Allen MI. Noonan phenotype associated with neurofibromatosis. Am J Med Genet. 1985;21:457\u201362.","journal-title":"Am J Med Genet"},{"key":"460_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12887-020-02102-z","volume":"20","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Chen X, Zhou R, Yin H, Xu J. Chinese patient with neurofibromatosis-Noonan syndrome caused by novel heterozygous NF1 exons 1\u201358 deletion: a case report. BMC Pediatr. 2020;20:190.","journal-title":"BMC Pediatr"},{"key":"460_CR18","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/humu.22832","volume":"36","author":"K Rojnueangnit","year":"2015","unstructured":"Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y, et al. High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation. Hum Mutat. 2015;36:1052\u201363.","journal-title":"Hum Mutat"},{"key":"460_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4274\/jcrpe.2070","volume":"8","author":"D Vuralli","year":"2016","unstructured":"Vuralli D, Gonc N, Vidaud D, Ozon A, Alikasifoglu A, Kandemir N. Growth hormone deficiency in a child with Neurofibromatosis-Noonan syndrome. J Clin Res Pediatr Endocrinol. 2016;8:96\u2013100.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"460_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22419","volume":"32","author":"N Mahdieh","year":"2018","unstructured":"Mahdieh N, Hosseini Moghaddam M, Motavaf M, Rabbani A, Soveizi M, Maleki M, et al. Genotypic effect of a mutation of the MYBPC3 gene and two phenotypes with different patterns of inheritance. J Clin Lab Anal. 2018;32: e22419.","journal-title":"J Clin Lab Anal"},{"key":"460_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijporl.2017.03.008","volume":"96","author":"M Motavaf","year":"2017","unstructured":"Motavaf M, Soveizi M, Maleki M, Mahdieh N. MYO15A splicing mutations in hearing loss: a review literature and report of a novel mutation. Int J Pediatr Otorhinolaryngol. 2017;96:35\u20138.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"460_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tripleo.2003.12.042","volume":"98","author":"M Yazdizadeh","year":"2004","unstructured":"Yazdizadeh M, Tapia JL, Baharvand M, Radfar L. A case of neurofibromatosis-Noonan syndrome with a central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:316\u201320.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"460_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4274\/jcrpe.galenos.2019.2019.0023","volume":"12","author":"E Isik","year":"2020","unstructured":"Isik E, Onay H, Atik T, Solmaz AE, Ozen S, Cogulu O, et al. A neurofibromatosis Noonan syndrome patient presenting with abnormal external genitalia. J Clin Res Pediatr Endocrinol. 2020;12:113\u20136.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"460_CR24","doi-asserted-by":"crossref","unstructured":"Qin S, Zhang Y, Yu F, Ni Y, Zhong J. A Novel heterozygous NF1 variant in a neurofibromatosis-Noonan syndrome patient with growth hormone deficiency: a case report. J Clin Res Pediatric Endocrinol. 2022.","DOI":"10.4274\/jcrpe.galenos.2022.2021-12-24"},{"key":"460_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.47803\/rjc.2020.31.4.903","volume":"31","author":"DN Radu","year":"2021","unstructured":"Radu DN, Dobrovie M, Capsa R. Neurofibromatosis 1-Noonan syndrome associated with pulmonary stenosis and hypertrophic cardiomyopathy. Roman J Cardiol. 2021;31:903\u201310.","journal-title":"Roman J Cardiol."},{"key":"460_CR26","doi-asserted-by":"publisher","first-page":"e14310917607","DOI":"10.33448\/rsd-v10i9.17607","volume":"10","author":"AA Carvalho","year":"2021","unstructured":"Carvalho AA, Martelli DR, Carvalho MF, Swerts MS. Cafe-au-lait spots as a clinical sign of syndromes. Res Soc Dev. 2021;10:e14310917607.","journal-title":"Res Soc Dev."},{"key":"460_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1399-0004.2006.00576.x","volume":"69","author":"DA Stevenson","year":"2006","unstructured":"Stevenson DA, Viskochil DH, Rope AF, Carey JC. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. Clin Genet. 2006;69:246\u201353.","journal-title":"Clin Genet"},{"key":"460_CR28","first-page":"225","volume":"32","author":"JM Boulanger","year":"2005","unstructured":"Boulanger JM, Larbrisseau A. Neurofibromatosis type 1 in a pediatric population: Ste-Justine\u2019s experience: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2005;32:225\u201331.","journal-title":"Le journal canadien des sciences neurologiques."},{"key":"460_CR29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/WNL.55.7.1067-a","volume":"55","author":"RG Curless","year":"2000","unstructured":"Curless RG. Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children. Neurology. 2000;55:1067\u20138.","journal-title":"Neurology"},{"key":"460_CR30","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.4238\/2012.July.10.6","volume":"11","author":"HX Tong","year":"2012","unstructured":"Tong HX, Li M, Zhang Y, Zhu J, Lu WQ. A novel NF1 mutation in a Chinese patient with giant cafe-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality. Genet Mol Res GMR. 2012;11:2972\u20138.","journal-title":"Genet Mol Res GMR"},{"key":"460_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/MOP.0000000000000169","volume":"27","author":"MA Karajannis","year":"2015","unstructured":"Karajannis MA, Ferner RE. Neurofibromatosis-related tumors: emerging biology and therapies. Curr Opin Pediatr. 2015;27:26\u201333.","journal-title":"Curr Opin Pediatr"},{"key":"460_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0945","volume":"4","author":"JP Landry","year":"2021","unstructured":"Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, et al. Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020. JAMA Netw Open. 2021;4: e210945.","journal-title":"JAMA Netw Open"},{"key":"460_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/08830738030180011601","volume":"18","author":"PI Agras","year":"2003","unstructured":"Agras PI, Baskin E, Sakallioglu AE, Arda IS, Ayter S, Oguzkan S, et al. Neurofibromatosis\u2013Noonan\u2019s syndrome with associated rhabdomyosarcoma of the urinary bladder in an infant: case report. J Child Neurol. 2003;18:68\u201372.","journal-title":"J Child Neurol"},{"key":"460_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/00043426-199903000-00014","volume":"21","author":"KJ Klopfenstein","year":"1999","unstructured":"Klopfenstein KJ, Sommer A, Ruymann FB. Neurofibromatosis-Noonan syndrome and acute lymphoblastic leukemia: a report of two cases. J Pediatr Hematol Oncol. 1999;21:158\u201360.","journal-title":"J Pediatr Hematol Oncol"},{"key":"460_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/cge.12568","volume":"88","author":"P Smpokou","year":"2015","unstructured":"Smpokou P, Zand DJ, Rosenbaum KN, Summar ML. Malignancy in Noonan syndrome and related disorders. Clin Genet. 2015;88:516\u201322.","journal-title":"Clin Genet"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-023-00460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-023-00460-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-023-00460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T06:08:36Z","timestamp":1676873316000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-023-00460-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1186\/s40246-023-00460-0","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained by the authors. The ethics committee approved this study of Guilan University of medical sciences (NO: IR.GUMS.REC.1401.237). Written consent was obtained from parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients\u2019 parents for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}